October 25, 2014 11:42 AM ET

Biotechnology

Company Overview of Archemix Corp.

Executive Profile

Andrew Ellington Ph.D.

Scientific Adviser, Traitwise, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Andrew Ellington, Ph.D., known as Andy, is Scientific Adviser of Traitwise, Inc. Dr. Ellington is an Associate Professor of Chemistry and Biochemistry at the University for Texas in Austin. As a professor at Indiana University and at the University of Texas, Dr. Ellington explores the potential of in vitro selection for developing pharmaceutical and diagnostic reagents. Dr. Ellington serves as member of scientific advisory board of Archemix Corp. Dr. Ellington developed ...

Corporate Headquarters

601 Montgomery Street
San Francisco, California 94111

United States

Phone: 415-962-4147
Fax: 415-367-9400

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD 1988
Harvard University
BS
Michigan State University
Post-Doctoral Training
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Archemix Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.